Related Experiment Video
Updated: Oct 10, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Paraneoplastic dermatomyositis and prostate cancer: Myopathy regression under cancer-directed therapy
Mafalda Miranda Baleiras1, Luís Maduro1, Carolina Vasques1
1Hospital São Francisco Xavier, Centro Hospitalar Lisboa Ocidental, Portugal.
Abstract:
Prostate cancer is the second most frequent malignancy in men worldwide and the fifth leading cause of death. Dermatomyositis (DM) is a rare idiopathic inflammatory myopathy characterized by musculocutaneous manifestations. However, DM can also present as a paraneoplastic syndrome of an underlying neoplasm. We report a case of a 65-year-old man diagnosed with prostate adenocarcinoma in the setting of severe dysphagia, muscle weakness and a facial erythematous rash. At first, the DM-related symptoms resolved with the initial treatment for the underlying malignancy. Yet, they flared up as the tumor progressed. To sum up, DM is a rare systemic disorder with unknown etiology. There is a well-established association between DM and malignancy. Malignancy-headed therapy can improve DM manifestations and the recurrence of DM symptoms may act as an early warning of malignancy relapse.
Insights
Dermatomyositis, a rare inflammatory disorder, can be a paraneoplastic syndrome associated with cancer. Treating the underlying malignancy improved symptoms, and their recurrence signaled tumor progression in a prostate cancer patient.
Area of Science:
- Rheumatology
- Oncology
- Dermatology
Background:
- Dermatomyositis (DM) is a rare idiopathic inflammatory myopathy with characteristic skin and muscle manifestations.
- DM can present as a paraneoplastic syndrome, indicating an underlying neoplasm.
- Prostate cancer is a significant global malignancy in men.
Purpose of the Study:
- To report a case of prostate adenocarcinoma presenting with dermatomyositis as a paraneoplastic syndrome.
- To highlight the relationship between dermatomyositis and underlying malignancy.
- To emphasize the potential of dermatomyositis symptoms as an early warning for malignancy recurrence.
Main Methods:
- Case report of a 65-year-old male patient.
- Clinical presentation included dysphagia, muscle weakness, and facial rash.
- Diagnosis of prostate adenocarcinoma and dermatomyositis.
Main Results:
- The patient's dermatomyositis symptoms initially improved with prostate cancer treatment.
- Dermatomyositis symptoms recurred and worsened as the prostate tumor progressed.
- This case illustrates the paraneoplastic association between prostate cancer and dermatomyositis.
Conclusions:
- Dermatomyositis is a rare systemic disorder with a known association with malignancy.
- Treatment targeting the underlying malignancy can lead to improvement in DM manifestations.
- Recurrence of DM symptoms may serve as an indicator of malignancy relapse, necessitating vigilant monitoring.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Targeted Cancer Therapies
There are several types of targeted therapies against...

